The human erythroleukemia K562 cell culture system for identification of inducers of fetal hemoglobin

Minerva Biotecnologica

Volumn 15, Issue 2, 2003, Pages 123-128

  Gambari, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

thalassemia; Ara C; Cystosine arabinoside; Fetal hemoglobin; K562 cells

Indexed keywords

AZACITIDINE; BUTYRIC ACID; CHROMOMYCIN; CISPLATIN; CISPLATIN DERIVATIVE; CYTARABINE; GAMMA GLOBIN; HEMIN; HEMOGLOBIN F; MITHRAMYCIN; TALLIMUSTINE;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN K 562; CONTROLLED STUDY; ERYTHROID CELL; ERYTHROLEUKEMIA CELL; GEL ELECTROPHORESIS; GENE EXPRESSION; HEMOGLOBIN DETERMINATION; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR MECHANICS; NORTHERN BLOTTING; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ARA; EUKARYOTA;

EID: 0242720379     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Rodgers GP, Rachmilewitz EA. Novel treatment options in the severe β-globin disorders. Br J Haematol 1995;91:263-8.
2. Olivieri NF, Weatherall DJ. The therapeutic reactivation of fetal haemoglobin. Hum Mol Genet 1998;7:1655-8.
3. Saleh AW, Hillen HF. Pharmacological induction of foetal haemoglobin synthesis in sickle-cell disease. Neth J Med 1997;51:169-78.
4. Rochette J, Craig JE, Thein SL. Fetal hemoglobin levels in adults. Blood Rev 1994;8:213-24.
5. Olivieri NF, Rees DC, Ginder DG, Thein SL, Waye JS, Chang L et al. Elimination of transfusions through induction of fetal hemoglobin synthesis in Cooley's anemia. Ann NY Acad Sci USA 1998;850:100-9.
6. Swank RA, Stamatoyannopoulos G. Fetal gene reactivation. Curr Opin Genet Dev 1998;8:366-70.
7. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995;332:1317-22.
8. Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S, Dover GJ. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood 1997;89:1078-88.
9. Dover GJ, Brusilow S, Samid D. Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate. N Engl J Med 1992;327: 569-70.
10. Fibach E, Prasanna P, Rodgers GP, Samid D. Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia. Blood 1993;82:2203-9.
11. Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med 1993,328:73-80.
12. Ikuta T, Atweh G, Boosalis V, White GL, Da Fonseca S, Boosalis M et al. Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene expression and hematopoiesis. Ann N Y Acad Sci 1998;850:87-99.
13. Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE et al. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders. N Engl J Med 1993;328:81-6.
14. Fibach E, Manor D, Oppenheim A, Rachmilewitz EA. Proliferation and maturation of human erythroid progenitors in liquid culture. Blood 1989;73:100-3.
15. Bianchi N, Osti F, Rutigliano C, Corradini FG, Borsetti E, Tomassetti M et al. The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells. Br J Haematol 1999;104:258-65.
16. Rutherford TR, Clegg JB, Weatherall DJ. K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature 1979;280:164-5.
17. Guerrasio A, Vainchenker W, Breton-Gorius J, Testa U, Rosa R, Thomopoulos P et al. Embryonic and fetal hemoglobin synthesis in K562 cell line. Blood Cells 1981;7:165-76.
18. Dean A, Erard F, Schneider AP, Schechter AN. Induction of hemoglobin accumulation in human K562 cells by hemin is reversible. Science 1981;212:459-61.
19. Plonczynski M, Hardy CL, Safaya S, Harrell A, McCoy L, Brinson A et al. Induction of globin synthesis in K562 cells is associated with differential expression of transcription factor genes. Blood Cells Mol Dis 1999;25:156-65.
20. Iyamu WE, Adunyah SE, Fasold H, Horiuchi K, Elford HL, Asakura T et al. Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin. Am J Hematol 2000;63:176-83.
21. Iyamu EW, Adunyah SE, Elford HL, Fasold H, Turner EA. Trimidox-mediated morphological changes during erythroid differentiation is associated with the stimulation of hemoglobin and F-cell production in human K562 cells. Biochem Biophys Res Commun 1998;247:759-64.
22. Hudgins WR, Fibach E, Safaya S, Rieder RF, Miller AC, Samid D. Transcriptional upregulation of gamma-globin by phenylbutyrate and analogous aromatic fatty acids. Biochem Pharmacol 1996;52:1227-33.
23. Cokic VP, Smith RD, Beleslin-Cokic BB, Njoroge JM, Miller JL, Gladwin MT et al. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J Clin Invest 2003;111:231-9.
24. Vadolas J, Wardan H, Orford M, Voullaire L, Zaibak F, Williamson R et al. Development of sensitive fluorescent assays for embryonic and fetal hemoglobin inducers using the human β-globin locus in erythropoietic cells. Blood 2002;100:4209-16.
25. Witt O, Monkemeyer S, Ronndahl G, Erdlenbruch B, Reinhardt D, Kanbach K et al. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood 2003;101:2001-7.
26. Witt O, Monkemeyer S, Kanbach K, Pekrun A. Induction of fetal hemoglobin synthesis by valproate: modulation of MAP kinase pathways. Am J Hematol 2002;71:45-6.
27. Bianchi N, Chiarabelli C, Borgatti M, Mischiati C, Fibach E, Gambari R. Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine. Br J Haematol 2001;113:951-61.
28. Witt O, Schmejkal S, Pekrun A. Tributyrin plus all-trans-retinoic acid efficiently induces fetal hemoglobin expression in human erythroleukemia cells. Am J Hematol 2000;64:319-21.
29. Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia-chromosome. Blood 1975; 45:321-34.
30. Cortesi R, Gui V, Osti F, Nastruzzi C, Gambari R. Human leukemic K562 cells treated with cytosine arabinoside: enhancement of erythroid differentiation by retinoic acid and retinol. Eur J Haematol 1998;61:295-301.
31. Cioè L, McNab A, Hubbell HR, Meo P, Curtis P, Rovera G. Differential expression of the globin genes in human leukemia K562(S) cells induced to differentiate by hemin or butyric acid. Cancer Res 1981;41:237-43.
32. Gambari R, Del Serino L, Barbieri R, Viola L, Tripodi M, Raschellà G et al. Human leukemia K-562 cells: induction of erythoid differentiation by 5-azacytidine. Cell Differ 1984;14:87-97.
33. Chiarabelli C, Bianchi N, Borgatti M, Prus E, Fibach E, Gambari R. Induction of gamma-globin gene expression by tallimustine analogs in human erythroid cells. Haematologica 2003;88:826-7.
34. Bianchi N, Ongaro F, Chiarabelli C, Gualandi L, Mischiati C, Bergamini P et al. Induction of erythroid differentiation of human K562 cells by cisplatin analogs. Biochem Pharmacol 2000;60:31-40.
35. Al-Khatti A, Papayannopoulou T, Knitter G, Fritsch EF, Stamatoyannopoulos G. Cooperative enhancement of F-cell formation in baboons treated with erythropoietin and hydroxyurea. Blood 1988;72:817-9.
36. Fibach E, Bianchi N, Borgatti M, Prus E, Gambari R. Mithramycin induces fetal hemoglobin production in normal and thalassemic human erythroid precursor cells. Blood 2003;102:1276-81.
37. Charache S, Dover GJ, Moore RD, Eckert S, Ballas SK, Kosthy M et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992;79:2555-65.
38. Sher GD, Ginder GD, Little J, Yang S, Dover GJ, Olivieri NF. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies. N Engl J Med 1995;332:1606-10.
39. Lowrey CH, Nienhuis AW. Brief report: treatment with azacytidine of patients with end stage β-thalassemia. N Engl J Med 1993; 329:845-8.
40. Wang G, Xu X, Pace B, Dean DA, Glazer PM, Chan P et al. Peptide nucleic acid (PNA) binding-mediated induction of human gamma-globin gene expression. Nucleic Acids Res 1999;27:2806-13.
41. Fibach E. Techniques for studying stimulation of fetal hemoglobin production in human erythroid cultures. Hemoglobin 1998;22:445-58.
42. Pope SH, Fibach E, Sun J, Chin K, Rodgers GP. Two-phase liquid culture system models normal human adult erythropoiesis at the molecular level. Eur J Haematol 2000;64:292-303.